Form D · Pharmaceuticals
AJNA BioSciences PBC
Littleton, CO · CIK 0001900590
Offering snapshot reported Jun 10, 2024 · SEC filing
- Reported sold
- $2.11M Offering amount: $2.11M
- Investors reported
- 57 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 28, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 10, 2024 | Initial | $2,105,106 | No comparison | 57 | SEC filing |
| Dec 21, 2021 | Initial | $6,870,000 | No comparison | 27 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-515597
In addition to the shares sold for cash, and the debt issued, $9,275,270.96 of convertible notes converted into shares of the Issuer's Preferred Stock.
Source: Form D, filed Jun 10, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Antony Caracciolo | Director |
| Gregory A. Gould | Executive |
| John Held | Director |
| Scott S. Humphreys | Executive |
| Rose Marcario | Director |
| Jared Stanley | Director |
| Jesse Stanley | Director |
| Joel Stanley | Director, Executive |
| Jacques Tortoroli | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
8022 Southpark Circle, Suite 500
Littleton, CO, 80120
Littleton, CO, 80120